Padzinska-Pruszynska I, Taciak B, Kiraga L, Smolarska A, Gorczak M, Kucharzewska P
Int J Mol Sci. 2025; 25(24.
PMID: 39769334
PMC: 11679359.
DOI: 10.3390/ijms252413569.
Gu X, Chen B, Zhang S, Zhai X, Hu Y, Ye H
Sci Rep. 2024; 14(1):31580.
PMID: 39738081
PMC: 11686015.
DOI: 10.1038/s41598-024-75750-1.
Kartal B, Garris C, Kim H, Kohler R, Carrothers J, Halabi E
Adv Sci (Weinh). 2024; 12(4):e2410360.
PMID: 39639496
PMC: 11775521.
DOI: 10.1002/advs.202410360.
Sao Marcos B, Santos D, de Sousa G, Cruz L, Barros B, de Sena M
Viruses. 2024; 16(11).
PMID: 39599846
PMC: 11599038.
DOI: 10.3390/v16111731.
Kumar V, Tomar A, Thapliyal A, Yadav S
Biochem Res Int. 2024; 2024:4288753.
PMID: 39309198
PMC: 11415250.
DOI: 10.1155/2024/4288753.
Microenvironment M1/M2 macrophages and tumoral progression vary within C57BL/6 mice from same substrain in prostate cancer model.
Hernandez-Peralta P, Chacon-Salinas R, Gracia-Mora M, Soldevila G, Moreno-Rodriguez J, Cobos-Marin L
Sci Rep. 2024; 14(1):15112.
PMID: 38956203
PMC: 11219814.
DOI: 10.1038/s41598-024-65960-y.
Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity.
Farhat-Younis L, Na M, Zarfin A, Khateeb A, Santana-Magal N, Richter A
Elife. 2024; 12.
PMID: 38885133
PMC: 11182644.
DOI: 10.7554/eLife.91999.
Deciphering the heterogeneity dominated by tumor-associated macrophages for survival prognostication and prediction of immunotherapy response in lung adenocarcinoma.
Sun J, Guo H, Nie Y, Zhou S, Zeng Y, Sun Y
Sci Rep. 2024; 14(1):9276.
PMID: 38653742
PMC: 11039664.
DOI: 10.1038/s41598-024-60132-4.
RAB5A in triple-negative breast cancer: a critical role in macrophage reshaping in an exosomal miR-21-dependent manner.
Qiao L, Dong C, Jia W, Sun G
Endocr Relat Cancer. 2024; 31(5).
PMID: 38470169
PMC: 11046356.
DOI: 10.1530/ERC-23-0257.
The trends and hotspots of immunotherapy for metastatic colorectal cancer from 2013 to 2022: A bibliometric and visual analysis.
Gong Y, Kang J, Wang M, Hayati F, Syed Abdul Rahim S, Wah Goh L
Hum Vaccin Immunother. 2024; 20(1):2312599.
PMID: 38356280
PMC: 10877983.
DOI: 10.1080/21645515.2024.2312599.
Macrophages and angiogenesis in human lymphomas.
Ribatti D, Tamma R, Annese T, Ingravallo G, Specchia G
Clin Exp Med. 2024; 24(1):26.
PMID: 38285283
PMC: 10824884.
DOI: 10.1007/s10238-023-01291-y.
Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy.
Kang X, Huang Y, Wang H, Jadhav S, Yue Z, Tiwari A
Pharmaceutics. 2024; 16(1).
PMID: 38258072
PMC: 10819517.
DOI: 10.3390/pharmaceutics16010061.
The Role of Cancer Stem Cell Markers in Ovarian Cancer.
Fraszczak K, Barczynski B
Cancers (Basel). 2024; 16(1).
PMID: 38201468
PMC: 10778113.
DOI: 10.3390/cancers16010040.
TonEBP expression is essential in the IL-1β-induced migration and invasion of human A549 lung cancer cells.
Song H, Kim T, Choi H, Kim S, Lee S
Oncol Res. 2024; 32(1):151-161.
PMID: 38188678
PMC: 10767233.
DOI: 10.32604/or.2023.030690.
Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer.
Meissner R, Wixler V, Wulfert F, Jacob J, Hale B, Robeck T
Mol Ther Oncolytics. 2023; 31:100741.
PMID: 38020062
PMC: 10679949.
DOI: 10.1016/j.omto.2023.100741.
The Immunological Landscape of M1 and M2 Macrophages and Their Spatial Distribution in Patients with Malignant Pleural Mesothelioma.
Laberiano-Fernandez C, Baldavira C, Machado-Rugolo J, Tamegnon A, Pandurengan R, AbSaber A
Cancers (Basel). 2023; 15(21).
PMID: 37958292
PMC: 10650059.
DOI: 10.3390/cancers15215116.
Targeted therapy for head and neck squamous cell carcinoma microenvironment.
Guo Z, Li K, Liu P, Zhang X, Lv J, Zeng X
Front Med (Lausanne). 2023; 10:1257898.
PMID: 37711747
PMC: 10498927.
DOI: 10.3389/fmed.2023.1257898.
AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages.
Hung C, Chen M, DeArmond D, Chiu C, Limboy C, Tan X
Cell Rep. 2023; 42(9):113067.
PMID: 37659081
PMC: 10577802.
DOI: 10.1016/j.celrep.2023.113067.
The Role of Extracellular Vesicles in the Pathogenesis of Hematological Malignancies: Interaction with Tumor Microenvironment; a Potential Biomarker and Targeted Therapy.
Das K, Mukherjee T, Shankar P
Biomolecules. 2023; 13(6).
PMID: 37371477
PMC: 10296653.
DOI: 10.3390/biom13060897.
Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung.
Shikanai S, Yamada N, Yanagawa N, Sugai M, Osakabe M, Saito H
Ann Surg Oncol. 2023; 30(12):7527-7537.
PMID: 37280312
PMC: 10562267.
DOI: 10.1245/s10434-023-13384-9.